Global Single-use Bioprocessing Systems Market: Snapshot
The world single-use bioprocessing systems market is analyzed to experience an apparent change in adoption patterns on the part of biopharmaceutical firms and biotechnology startups. This shift is primarily steered in the direction of single-use technologies. Over the recent years, there has been an upscale growth observed in the world market, not just on account of the acceptance of single-use technologies. The biopharmaceutical sector is advancing toward maturation at a swift rate. In this regard, novel treatment solutions are being cumulatively concentrated upon by a majority of organizations. Such treatment solutions are esteemed to have a contracted pipeline for development and come across unprecedented compared to those of other competitors in the market.
As per the profound analysis performed by the expert researchers at Transparency Market Research (TMR), the global single-use bioprocessing systems market is prognosticated to leapfrog at a decent CAGR of 11.1% between 2016 and 2024. The global market had raked in an impressive US$2.3 bn in 2015 and is expected to keep coining it while maintaining the same pace to reach US$5.9 bn by the concluding year of the forecast period.
Monoclonal Antibody Production Towers over Other Applications with Topping Share
The worldwide single-use bioprocessing systems market finds application in a variety of biotechnology segments such as patient specific cell therapies, plant cell cultivation, vaccine production, and monoclonal antibody production. Amongst these, for the forecast period, the monoclonal antibody production segment is anticipated to secure a whopping 66.0% share in the worldwide market at a significant CAGR. The success of this market is stemmed from the important support by the U.S. and Europe governments which gave the green signal in 2015 for 10 antibody therapeutics. The latest consents given by the U.S. Food and Drug Administration (FDA) and European Union (EU) for monoclonal antibodies have offered a strong boost to the monoclonal antibody production segment. Much of the demand is also attributed to the clinical trial phases accommodating a robust increase in the count of monoclonal antibodies.
Bioprocessing bags are one product which have gained immense impetus in the global single-use bioprocessing technologies market. This could be on account of their extensive usage across a gamut of applications such as transfer, storage, mixing, and filtration during the production of drug molecules, vaccines, and monoclonal antibodies. Besides different downstream and upstream functions, bioprocessing bags can be customized as per the requirements of end users.
With a swelling awareness about the advantages of single-use bioprocessing technologies, the pharmaceuticals market is envisioned to take grip of a colossal share in terms of end user.
Europe and North America Lead Global Market Shoulder to Shoulder
There has been a pilot adoption of single-use bioprocessing technologies by specialized multiproduct biopharmaceutical and biotechnology firms, not to forget contract research organizations (CROs) and contract manufacturing organizations (CMOs), in Europe and North America. As a result, both the regions had shared their dominance in the global single-use bioprocessing technologies market in 2015 and are predicted to continue with it until 2024. The clustered developments and innovations in bioscience and avant-garde biologics research and development in these geographies could raise the bar of revenue growth. Besides this, most giant vendors in the field have headquartered their companies in Europe and North America, which is undoubtedly prophesied to welcome higher shares in these regions.
The elevated unmet need of the developing countries in Asia Pacific regarding revolutionary vaccines and therapies for cancer could offer lucrative hopes for the region in the single-use bioprocessing technologies market. The Asia Pacific market is not only poised on the back of its disease-burdened population but also the resourceful contract research services furnished to China and India by various pharmaceutical organizations.
Single-use Bioprocessing Systems Market: Trends and Opportunities
Bioprocessing is a significant part of biopharmaceutical development and production processes and single-use bioprocessing systems, which are meant for one-time use, have recently found their unique position in the biopharmaceutical and biotherapeutics industry. Biomanufacturing facilities which once housed only stainless steel equipment are paving the way for a hybrid setup which also incorporates single-use technologies. New facilities manufacturing biologics, especially CRO’s/CMO’s and small biotechnology startups are increasingly opting for fully single-use plants. These systems have made the production of clinical trial drugs as well as commercially manufactured drugs cost-effective and flexible. The market for single-use bioprocessing systems is expected to grow at a double-digit figure during the forecast period from 2016 to 2024 and shall be driven by factors such as lowered labor efforts, lowered capital cost, and riddance of time, money, and efforts spent on sterilization procedures.
Single-use Bioprocessing Systems Market: Scope and Methodology
This report on the global single-use bioprocessing systems market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments. The research is a combination of primary and secondary research. Detailed qualitative analysis of factors responsible for driving and restraining market growth and opportunities has been provided in the market overview section. Market revenue in terms of US$ Mn for the period between 2014 and 2024 along with the compound annual growth rate (CAGR %) from 2016 to 2024 are provided for all the segments, considering 2015 as the base year. Market related factors such as technological developments, product innovation, expansion of infrastructural facilities by major and small pharmaceuticals, and historical year-on-year growth have been taken into consideration while estimating the market size. Growth rates for each segment within the global single-use bioprocessing systems market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, drug development life cycle, and regulatory requirements. These factors would help the market players to take strategic decisions in order to strengthen their positions and expand their share in the global market.
Single-use Bioprocessing Systems Market: Segmentation
Based on product type, the global single-use bioprocessing systems market has been segmented into bioreactors and fermenters, mixers, bags, filtration devices, tubing, sampling systems, connectors & clamps, and sensors & probes. Bags and bioreactors are the most prominently selling products in the single-use bioprocessing systems market.
Major end-users of single-use bioprocessing systems include pharmaceutical organizations, biotechnology organizations, CRO’s & CMO’s, and academic and research institutes. In terms of applications, the market has been segmented into monoclonal antibody production, vaccine production, plant cell cultivation, patient specific cell therapies, and others. The others segment includes recombinant proteins, enzymes, growth factors etc. The flexibility of single-use systems coupled with the decreased concern related to chances of cross contamination, make single-use bioprocessing systems a prime purchase option for manufacturers involved in monoclonal antibody production.
Geographically, the global single-use bioprocessing systems market has been segmented into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The regions have been further segmented by major countries. A global overview has been provided, and the North America region has been analyzed in depth at country as well as product, application, and end-user segment level. The countries in North America section include the U.S. and Canada. The regions of Europe, Asia Pacific, Latin America, and Middle East & Africa have been briefly profiled at country level. The countries include the U.K., Germany, France, Italy, China, Japan, Australia & New Zealand, Brazil, Mexico, the UAE, and South Africa.
Single-use Bioprocessing Systems Market: Competitive Landscape
The competition matrix section included in the report is likely to assist the existing players to increase their market shares and new companies to establish their presence in the single-use bioprocessing systems market. The report also profiles major players in the single-use bioprocessing systems market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments. Key companies profiled in the report include Thermo Fisher Scientific, Merck KGaA (Merck Millipore), Danaher Corporation (Pall Corporation), Sartorius AG, Eppendorf AG, GE Healthcare, PBS Biotech, Inc., Meissner Filtration Products, Finesse Solutions, Sentinel Process Solutions, and Saint-Gobain.
The global single-use bioprocessing systems market has been segmented as follows:
Global Single-use Bioprocessing Systems Market, by Product
- Bioreactors & Fermenters
- Bioprocess Containers
- Filtration Devices
- Sampling Systems
- Connectors & Clamps
- Probes & Sensors
Global Single-use Bioprocessing Systems Market, by End-user
- CRO & CMO
- Academic & Research Institutes
Global Single-use Bioprocessing Systems Market, by Application
- Monoclonal Antibody Production
- Vaccine Production
- Plant Cell Cultivation
- Patient Specific Cell Therapies
- Others (production of enzymes, growth factors etc.)
Global Single-use Bioprocessing Systems Market, by Geography
- North America
- Asia Pacific
- Australia & New Zealand
- Rest of APAC
- Rest of Europe
- Latin America
- Rest of Latin America
- Middle East & Africa
- South Africa
- Rest of Middle East & Africa